What Arm Holdings Actually Does
Arm doesn't make chips. Arm licenses the instruction set architecture (ISA) and CPU core designs that other companies use to build chips. If you own an iPhone, Android phone, MacBook, or access an AWS server, you are using ARM-based chips. More than 99% of the world's smartphones run ARM architecture. Apple's M-series chips — the most powerful laptop CPUs on the market — are ARM-based. NVIDIA's Grace CPU, used in AI servers, is ARM-based. AWS Graviton, used across Amazon's cloud infrastructure, is ARM-based.
Arm earns money two ways: upfront license fees when chip designers license its IP to build new chips, and royalties when those chips are shipped. License revenue is lumpy — it comes in large payments when a new chip design is licensed. Royalty revenue is durable and compounding — it grows as more ARM-based chips ship worldwide. These two streams need to be understood separately to make sense of any given quarter.
Q1 FY2027 Results (Quarter Ended June 30, 2026)
- Revenue: $1.289B vs $1.27B consensus — BEAT | +22.41% YoY
- EPS (non-GAAP): $0.45 vs $0.40 estimate — BEAT by 12.5%
- EPS (GAAP): $0.25 — significantly lower due to share-based compensation
- Royalty Revenue: $715M — +22% YoY vs $585M Q1 FY2026
- License Revenue: $574M — down sharply from Q4 FY2026's $819M
- Gross Profit: $1.253B (97.2% gross margin)
- Operating Income (GAAP): $91M — low due to heavy SBC
- Net Income (GAAP): $270M
- Net Cash: $3.424B
Record Q1 revenue. Beat on both revenue and EPS. Royalties growing at 22% year-over-year. Management highlighted AGI CPU demand exceeding $2 billion and noted "cloud AI overperformance" as a key driver. These are good numbers for a good business. And yet the stock fell 14% combined on the day and after-hours. The reason is not in these numbers — it's in the multiple attached to them.
License vs Royalty: Understanding the Mix
The sequential drop in license revenue from $819M (Q4 FY2026) to $574M (Q1 FY2027) is large and needs context. License revenue is inherently lumpy — Arm collects a large upfront payment when a chip designer like Apple, NVIDIA, or Qualcomm licenses a new CPU design. Those payments don't arrive on a predictable schedule. Q4 tends to be seasonally strong for licenses (end of fiscal year deal signings), and Q1 reflects the natural pause after that activity.
The royalty line is the real underlying growth engine: $715M in Q1 FY2027 vs $585M in Q1 FY2026 (+22.2%). Royalties grow as more ARM-based chips ship — and the royalty rate per chip has been rising as customers shift to more advanced ARM cores (Armv9, CSS platforms) that carry higher per-unit royalties. This is the compounding machine underneath the license noise. When you're evaluating ARM as a long-term hold, the royalty trajectory is what you're paying for.
The AI Signal: AGI CPU Demand Exceeds $2B
Management's call-out that "AGI CPU demand exceeds $2B" is the most strategically important disclosure in the quarter. ARM CPUs are increasingly powering AI inference workloads alongside GPU accelerators. NVIDIA's Grace Hopper Superchip pairs ARM CPUs with H100/H200 GPUs — every time NVIDIA ships a Grace-based system, Arm collects a royalty. AWS Graviton servers run ARM CPUs and are the preferred infrastructure for cost-efficient AI inference on Amazon's cloud. Microsoft Azure is expanding ARM-based instances. Google is developing ARM-based chips for its data centers.
This is the structural bet on ARM: AI inference at scale runs on data center infrastructure that increasingly incorporates ARM CPUs. As AI inference workloads grow — driven by model deployment, API calls, enterprise AI adoption — the royalty base grows proportionally. The smartphone market (still ARM's largest end market) is flattening, but cloud and data center is picking up the slack and then some. Q1's royalty beat on smartphone softness is evidence this transition is working.
The GAAP vs Non-GAAP Gap
ARM's GAAP EPS of $0.25 vs non-GAAP EPS of $0.45 represents a $0.20 per share gap — almost entirely from share-based compensation. This is a common pattern at post-IPO tech companies where founders, employees, and early investors hold large equity grants that vest over time. The SBC expense is real — it represents economic dilution — but doesn't consume cash. For valuation purposes, most analysts use non-GAAP EPS because the operating cash generation is what matters for the business thesis. That said, GAAP net income of $270M on $1.289B in revenue is a 20.9% GAAP profit margin, which is real and growing.
Why the Stock Dropped on a Beat
ARM entered today at $224.89 and closed -8.11% before earnings. Then the print came — beat on revenue, beat on EPS, record quarter — and the stock fell another 5.73% in after-hours to $212. This is what "priced for perfection" means in practice.
At $212 in after-hours, ARM's market cap is approximately $222B. Against TTM revenue of $5.156B, that's 43x price/sales. Against the forward EPS estimate, it's over 100x forward PE. For a company growing revenue at 22–25% annually, that multiple requires flawless execution with no negative surprises for multiple years. When a stock is priced this way, even a solid beat-and-raise isn't enough — the market is disappointed because "solid" is already embedded in the price. The quarterly sequential decline in license revenue from $819M to $574M gave sellers something to point to, even though it's a predictable seasonal pattern. At 100x earnings, sentiment shifts fast.
The Quarterly Trajectory
| Quarter | Revenue | Royalty | License | YoY Growth |
|---|---|---|---|---|
| Q1 FY2026 (Jun '25) | $1.053B | $585M | $468M | +12.14% |
| Q2 FY2026 (Sep '25) | $1.135B | $620M | $515M | +34.48% |
| Q3 FY2026 (Dec '25) | $1.242B | $737M | $505M | +26.35% |
| Q4 FY2026 (Mar '26) | $1.490B | $671M | $819M | +20.06% |
| Q1 FY2027 (Jun '26) | $1.289B | $715M | $574M | +22.41% |
The pattern is visible: Q4 FY2026 was a large license quarter ($819M) that pulled forward deals, making the Q1 sequential comparison look weak. Royalties, the structural story, have been compounding steadily: $585M → $620M → $737M → $671M → $715M. Q3's $737M royalty quarter was the highest ever; Q1 at $715M is strong. The annual royalty run rate is approximately $2.8B and growing.
Valuation: The Honest Assessment
- Price at close: $224.89 | AH price: $212.00
- TTM Revenue: $5.156B
- TTM EPS (GAAP): $0.97 | Non-GAAP est.: ~$1.60–1.70
- Forward PE (at $212): ~100–110x depending on estimates
- Price/Sales (at $212): ~43x TTM
- FCF (TTM): $1.506B | P/FCF (at $212): ~148x
- Net Cash: $3.424B — clean balance sheet
There is no valuation framework that makes ARM "cheap" at current prices. The bull case requires belief that ARM's royalty base continues growing 20–25% annually for the next 5+ years, driven by AI workload expansion in data centers, compounding smartphone royalty rates, and potential new markets (automotive, IoT, data center CPUs). If that happens, today's multiple compresses rapidly on the rising earnings base. The bear case is that the multiple is simply too high to sustain — that any slowdown in royalty growth or license deal timing creates a quarter like today where even a beat generates a 14% decline.
Position Framework
- Setup: High-quality IP licensor with legitimate AI tailwinds, trading at a premium that reflects 5+ years of expected growth upfront
- Entry (aggressive): $195–$210 — the flush zone if AH selling extends to open; only appropriate for a small spec allocation given the multiple
- Entry (patient): $165–$180 — a more defensible multiple on FY2027/2028 forward earnings if the stock re-rates to 70–75x forward
- Add trigger: Two consecutive quarters of royalty revenue above $750M (signals structural AI-driven royalty acceleration, not just smartphone recovery)
- Trim zone: $260–$280 if the AH reversal sticks and buyers return to AI momentum names
- Target: $250–$300 on 12-month view — but only if royalty growth re-accelerates above 25% YoY
- Invalidation: Royalty revenue decelerates below 10% YoY for two consecutive quarters, or a major customer (Apple, NVIDIA, Qualcomm) announces a competing in-house ISA strategy that would eventually reduce royalties
- Hard truth: At $212–$224, you are paying for a decade of growth in advance. That works if the growth materializes. It is a very painful trade if the royalty trajectory disappoints — the multiple compression alone can cut the stock in half without the underlying business being "broken."
ARM is not a bad business — it is one of the most important IP businesses in the world. Every major semiconductor platform is built on ARM architecture. The AI data center shift is a genuine tailwind for royalties. The problem is the price. At $212, you're paying 43x revenue for a 22%-growth IP licensor. The stock needs 3–4 more years of compounding before those numbers look reasonable in retrospect. That's a long time to hold at 100x earnings with a volatile semiconductor cycle underneath you.